Physician

Emergency Medicine

Gregory D. Sides, MD is an expert in the field of Emergency Medicine. Gregory Sides is also a published MD. He has 23 publication published. The most recent publication is: Effect of dirithromycin on human CYP3A in vitro and on pharmacokinetics and pharmacodynamics of terfenadine in vivo.

Publications

---

• A phase 2 dose-ranging study of subcutaneous tabalumab for the treatment of patients with active rheumatoid arthritis and an inadequate response to methotrexate.
• Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia.
• Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate.
• Semen and sperm reference ranges for men 45 years of age and older.
• Impact of a soluble phospholipase A2 inhibitor on inhaled allergen challenge in subjects with asthma.
• The Influence of Dirithromycin on the Pharmacokinetics of Cyclosporine in Healthy Subjects and in Renal Transplant Patients.
• Clinical efficacy of dirithromycin in patients with bacteremic pneumonia.
• Clinical efficacy of dirithromycin in acute exacerbations of chronic bronchitis.
• New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy.
• New directions for macrolide antibiotics: structural modifications and in vitro activity.
• Pharmacokinetics of dirithromycin.
• Dirithromycin in the treatment of streptococcal pharyngitis.
• Effect of dirithromycin on human CYP3A in vitro and on pharmacokinetics and pharmacodynamics of terfenadine in vivo.
• A comprehensive review of the clinical pharmacology and pharmacokinetics of cefaclor.
• Safety profile of dirithromycin.
• Comparison of dirithromycin and penicillin for treatment of streptococcal pharyngitis.
• Five-day dirithromycin therapy is as effective as seven-day erythromycin therapy for acute exacerbations of chronic bronchitis.
• Comparative efficacy of 5 days of dirithromycin and 7 days of erythromycin in skin and soft tissue infections.
• A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumato...
• QT interval prolongation as a biomarker for torsades de pointes and sudden death in drug development.
• The efficacy of tadalafil in improving sexual satisfaction and overall satisfaction in men with mild, moderate, and severe erectile dysfunction: a retrospective pooled...
• Retinal effects of 6 months of daily use of tadalafil or sildenafil.

Schools

---

• Indiana University School Of Medicine

• Methodist Hospital

Doctors Specialties

---

• Emergency Medicine
• Internal Medicine

Accepted Insurances

---

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Fred Mo, DO This Doctor is OpenDoctor Recommended.
	Dr. Elisabeth D. Kline, MD This Doctor is OpenDoctor Recommended.
	Dr. Eugene Kligman, MD
	Dr. Ankur A. Patel, MD
	Dr. James M. Hotz, MD
	Dr. Albert L. Blake, MD This Doctor is OpenDoctor Recommended.
	Dr. Ryan R. Venis, MD This Doctor is OpenDoctor Recommended.
	Dr. Charles Miramonti, MD This Doctor is OpenDoctor Recommended.
	Dr. Tyler M. Stepsis, MD This Doctor is OpenDoctor Recommended.
	Dr. Joseph N. Gaddy, MD
	Dr. Gregory R. Snead, MD This Doctor is OpenDoctor Recommended.
	Dr. Timothy J. Pettigrew, MD This Doctor is OpenDoctor Recommended.
	Dr. Roderick G. Morrison, MD This Doctor is OpenDoctor Recommended.
	Dr. Mona S. Saifullah, MD This Doctor is OpenDoctor Recommended.
	Dr. Jack Keene, MD This Doctor is OpenDoctor Recommended.
	Dr. Aloysius Humbert, MD This Doctor is OpenDoctor Recommended.
	Dr. Kaia M. Knutson, MD This Doctor is OpenDoctor Recommended.
	Dr. Brian Sloan, MD This Doctor is OpenDoctor Recommended.
	Dr. Nash P. Whitaker, MD This Doctor is OpenDoctor Recommended.
	Dr. Bo J. Beus, MD This Doctor is OpenDoctor Recommended.
	Dr. Carly D. Snipes, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog